419 related articles for article (PubMed ID: 24262876)
1. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
2. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
Denehy TR; Gregori CA; Breen JL
Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cervical conization as a definitive treatment for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3.
Takeda N; Suzuki T; Suzuki M; Matsuura M; Tanaka R; Fujii M; Ito E; Saito T
Arch Gynecol Obstet; 2012 Feb; 285(2):453-7. PubMed ID: 21681515
[TBL] [Abstract][Full Text] [Related]
4. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
[TBL] [Abstract][Full Text] [Related]
5. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Poynor EA; Barakat RR; Hoskins WJ
Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
[TBL] [Abstract][Full Text] [Related]
6. Conservative Treatment for Patients with Carcinoma in Situ-Positive Margins After a Loop Electroexcisional Procedure: Is It Safe?
Chong GO; Lee YH; Lee YS; Cho YL; Park JY; Hong DG
J Reprod Med; 2017; 62(1-2):37-44. PubMed ID: 29999280
[TBL] [Abstract][Full Text] [Related]
7. Is there any predictor for residual disease after cervical conization with positive surgical margins for HSIL or microinvasive cervical cancer?
Tasci T; Turan T; Ureyen I; Karalok A; Kalyoncu R; Boran N; Tulunay G
J Low Genit Tract Dis; 2015 Apr; 19(2):115-8. PubMed ID: 25259663
[TBL] [Abstract][Full Text] [Related]
8. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
Goldstein NS; Mani A
Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
[TBL] [Abstract][Full Text] [Related]
9. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
Im DD; Duska LR; Rosenshein NB
Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
[TBL] [Abstract][Full Text] [Related]
10. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma in situ of the cervix: management and outcome.
Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in situ of the uterine cervix.
Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
[TBL] [Abstract][Full Text] [Related]
13. Is conization once following by simple hysterectomy sufficient for all clinical stage IA1 cervical squamous cell carcinoma?
Chen JR; Chiu ML; Wang TY; Chen TC; Wang KG; Su TH; Chang CL; Yang YC; Wang KL
Taiwan J Obstet Gynecol; 2013 Sep; 52(3):385-8. PubMed ID: 24075378
[TBL] [Abstract][Full Text] [Related]
14. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen.
Roman LD; Felix JC; Muderspach LI; Agahjanian A; Qian D; Morrow CP
Obstet Gynecol; 1997 Nov; 90(5):759-64. PubMed ID: 9351760
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors of predicting residual disease in women with stage I a1 squamous cervical carcinoma after conization].
Zhu XE; Feng Y; Fu YF; Cheng XD; Chen XD; Xie X; Lü WG
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(7):534-6. PubMed ID: 23660325
[TBL] [Abstract][Full Text] [Related]
16. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
[TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
18. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
20. Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins.
Itsukaichi M; Kurata H; Matsushita M; Watanabe M; Sekine M; Aoki Y; Tanaka K
Gynecol Oncol; 2003 Aug; 90(2):387-9. PubMed ID: 12893205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]